Contact
Score Calculators

Governance

Board of TrusteesGoverning BoardScientific Advisory Board

Executive Team

Grifols Chair Directorate

Board of Trustees

In accordance with the Foundation’s Statements, the Board of Trustees exerts its roles of governance and management as a representative body of the Foundation. The Board of Trustees is responsible for ensuring that the Foundation’s goals are fulfilled, and for duly administrating the goods and rights that are drawn by of the Foundation to guarantee the maintenance of the Foundations’ resources and their use. The Board of Trustees is required to approve an audited financial statement for each financial year.

Richard Moreau

President, 2025 – present

Richard Moreau was appointed Director of EF CLIF in January 2024. He is founding member of the EASL-CLIF Consortium (2009), former member of the EASL-CLIF Consortium Steering Committee (2009–2018); former Deputy Director of the Grifols Chair (2015–2021); former Honorary Director of the Grifols Chair (2022–2024); former Chair of the Scientific Advisory Board of EF CLIF (2021–2024).

Since September 2018, he is Emeritus Senior Scientist at INSERM, Paris, France; he is former Senior Scientist (Directeur de Recherche de Classe Exceptionnelle (2013)) at the INSERM. He is former Deputy Director of the Center for Research on Inflammation (2014–2018); former Director of Center of Biomedical Research Bichat-Beaujon (2013); former Head of Successive Research teams on pathophysiology and treatment of cirrhosis appointed by INSERM and University Paris-Cité (2005–2018). He is former Co-Chair (with Prof. Shiv K. Sarin) of the international Indo-French Laboratory for the Study of Advanced Liver Diseases endorsed by the INSERM, the University Paris-Cité in France, and the Institute of Liver and Biliary Sciences (ILBS), New Delhi, India (1993–2022).

Moreau obtained his MD degree in 1983 at the University of Paris, France, and completed his residency in the departments of Internal Medicine, Diabetology, Nephrology and Intensive Care at Île-de-France hospitals (1978–1982), where he was a full-time physician in Intensive Care Units (1983–1996). He is former Consultant in Hepatology, co-responsible of the Hemodynamic Laboratory of the Liver Unit at Hôpital Beaujon AP-HP, Clichy, France (1996–2023).

He served as Special Section Editor (2020–2021), Senior Editor (2015–2019) and Associate Editor (2010–2014) for of Journal of Hepatology; and Associate Editor for Liver International (2007–2009). He is an active member of the European Association for the Study of the Liver (EASL), American Association for the Study of Liver Diseases (AASLD), Asian Pacific Association for the Study of the Liver (APASL), French Association for the Study of the Liver (AFEF), and Club Francophone pour l’Etude de l’Hypertension Portale.

Mauro Bernardi

Appointed Trustee, 2015 – present

Emeritus Professor of Internal Medicine at University of Bologna, Italy. Mauro Bernardi was former Director of the Department of Internal Medicine and Hepatology (2000–2006) and Postgraduate School in Internal Medicine (2013–2016) at the University of Bologna, Italy, where he has also served as the Chair of the Research Observatory (2010–2013) and Bioethics Committee (2016–2022). From 1978 to 1981, Bernardi was a member of the Scientific Committee of the Italian Association for the Study of the Liver (AISF). From 2008 to 2019, he served as the Treasurer of the European Association for the Study of the Liver (EASL); and from 2009 to 2019, he served as the Vice-Chair of the EASL-CLIF Consortium Steering Committee. Bernardi has received the Distinguished Service Awards from the AISF (2015) and the Hilfenhaus Award from the Plasma Protein Therapeutics Association (PPTA) (2018).

Antonio Páez

Appointed Trustee, 2017 – present

Vice-President of Scientific and Medical Affairs, Scientific Innovations Office at Grifols, Spain. Antonio Páez is a physician and physicist. As a physician, he holds a medical degree (1992) from the Autonomous University of Barcelona, Spain, and specialized in Hematology and Hemotherapy. From 1993 to 1996, Páez gained clinical practice expertise at Hospital Universitari Sagrat Cor and Hospital Clínic de Barcelona, Spain, and Mount Sinai Medical Center, NY, USA. In 2010, he obtained a degree in Physical Science from the Open University, UK. In 1998, Páez joined the Medical Department at AMGEN’s affiliate in Spain, and joined the Corporate Medical Division at Almirall in 2001. In 2004, he joined Grifols where he has held different positions within the Clinical Trials Department before being appointed Medical Director of the Plasma Protein Replacement Therapies Group. He is currently the Vice President of Scientific and Medical Affairs at Grifols.

Ignasi Bruguer

Appointed Trustee, 2023 – present

Director/Counsel at Osborne Clarke, Spain. Ignasi Bruguer graduated in Law (2011) from the University of Barcelona, Spain. With more than 10-year experience as the legal advisor and secretary to the board of different profit and non-profit organizations, Bruguer is a corporate transactions lawyer specializing in mergers and acquisitions who has also advised several R&D spin-offs and start-ups from different research organizations.

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024